Baugh & Associates LLC Purchases New Shares in Danaher Corporation $DHR

Key Points

• Baugh & Associates LLC acquired 72,668 Danaher shares in the third quarter, worth approximately $16.1 million and representing 5.5% of its portfolio. Institutional investors collectively own 79.05% of Danaher.
• Analyst sentiment remains favorable, with Danaher carrying a consensus “Moderate Buy” rating and an average price target of $235.41; recent targets range from $195 to $255.
• Danaher reported quarterly revenue of $6.26 billion and adjusted earnings of $1.94 per share, exceeding estimates, while declaring a quarterly dividend of $0.40 per share.

Baugh & Associates LLC bought a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 72,668 shares of the conglomerate's stock, valued at approximately $16,100,000. Danaher comprises about 5.5% of Baugh & Associates LLC's portfolio, making the stock its 4th biggest holding.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Veery Capital LLC raised its position in Danaher by 3.1% in the third quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate's stock valued at $350,000 after purchasing an additional 48 shares during the period. Studio Investment Management LLC lifted its holdings in Danaher by 3.3% during the 2nd quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate's stock worth $302,000 after buying an additional 51 shares during the last quarter. JDH Wealth Management LLC raised its position in shares of Danaher by 4.5% during the 1st quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate's stock worth $240,000 after acquiring an additional 55 shares in the last quarter. OLD Second National Bank of Aurora raised its position in shares of Danaher by 0.5% during the 1st quarter. OLD Second National Bank of Aurora now owns 12,114 shares of the conglomerate's stock worth $2,297,000 after acquiring an additional 57 shares in the last quarter. Finally, Adelphi Trust Co lifted its stake in Danaher by 2.5% during the third quarter. Adelphi Trust Co now owns 2,365 shares of the conglomerate's stock worth $524,000 after purchasing an additional 57 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Wall Street Analyst Weigh In

DHR has been the subject of several research analyst reports. Wall Street Zen upgraded shares of Danaher from a "hold" rating to a "buy" rating in a research note on Saturday, October 10th. Wells Fargo & Company reduced their price target on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating for the company in a research report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. TD Cowen raised their price objective on shares of Danaher from $236.00 to $255.00 and gave the stock a "buy" rating in a research report on Tuesday. Finally, Evercore reaffirmed an "outperform" rating and issued a $230.00 target price on shares of Danaher in a report on Monday, July 6th. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $235.41.

Danaher Stock Down 1.1%

Shares of NYSE DHR opened at $228.87 on Friday. The firm's 50 day moving average price is $214.04 and its 200 day moving average price is $195.97. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The firm has a market cap of $160.89 billion, a P/E ratio of 40.65, a price-to-earnings-growth ratio of 2.91 and a beta of 0.76. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same quarter in the prior year, the company posted $0.77 EPS. The business's revenue for the quarter was up 5.5% compared to the same quarter last year. As a group, sell-side analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher's dividend payout ratio is presently 28.42%.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.